-

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Mercury Systems, Inc. (MRCY) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Mercury Systems, Inc. (“Mercury” or the “Company”) (NASDAQ: MRCY) investors concerning the Company’s possible violations of federal securities laws.

On July 26, 2022, Glasshouse Research published a report alleging that Mercury’s organic revenue is “overstated,” that its Physical Optics acquisition has been a “disaster,” and that management has prematurely recognized revenues.

On this news, Mercury’s stock fell $4.87, or 7.8%, to close at $57.26 per share on July 26, 2022, thereby injuring investors.

Then, on August 2, 2022, after the market closed, Mercury announced its fourth quarter and full year 2022 financial results, reporting $289.7 million in quarterly revenue, which is below prior guidance expecting revenue between $301.5 million and $321.5 million. The Company attributed the shortfall to “material and order delays that affected the timing of revenue.”

On this news, the Company’s stock fell as much as 13% during intraday trading on August 3, 2022, thereby injuring investors further.

If you purchased Mercury securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Law Offices of Howard G. Smith

NASDAQ:MRCY

Release Versions

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Law Offices of Howard G. Smith Encourages NuScale Power Corporation (SMR) Shareholders to Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR) common stock between May 13, 2025 and November 6, 2025, inclusive (the “Class Period”). NuScale investors have until April 20, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NUSCALE POWER CORPORATION (SMR), CONTACT THE LAW OFFICES OF HOWARD G...

Nuscale Power Corporation (SMR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Nuscale Power Corporation (“Nuscale” or the “Company”) (NYSE: SMR) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NUSCALE POWER CORPORATION (SMR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rig...

Deadline Approaching: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming April 7, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INOVIO PHARMACEUTICALS, INC. (INO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PA...
Back to Newsroom